Chemoinformaics analysis of Arctigenin-4-Beta-D-Glucopyranoside
| Molecular Weight | 534.558 | nRot | 10 |
| Heavy Atom Molecular Weight | 500.286 | nRig | 24 |
| Exact Molecular Weight | 534.21 | nRing | 4 |
| Solubility: LogS | -3.366 | nHRing | 2 |
| Solubility: LogP | 1.015 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 76.583 |
| nHD | 4 | BPOL | 45.393 |
| QED | 0.315 |
| Synth | 4.108 |
| Natural Product Likeliness | 1.664 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.135 |
| Pgp-sub | 0.177 |
| HIA | 0.098 |
| CACO-2 | -5.484 |
| MDCK | 0.0000688 |
| BBB | 0.352 |
| PPB | 0.725913 |
| VDSS | 0.362 |
| FU | 0.161853 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.364 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.861 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.333 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.886 |
| CYP3a4-inh | 0.279 |
| CYP3a4-sub | 0.437 |
| CL | 8.01 |
| T12 | 0.573 |
| hERG | 0.21 |
| Ames | 0.138 |
| ROA | 0.023 |
| SkinSen | 0.056 |
| Carcinogencity | 0.493 |
| EI | 0.007 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.722 |
| Antiviral | Yes |
| Prediction | 0.949093 |